Related Experiment Video
Updated: Jun 6, 2026
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Mutant p53 Gain of Function: Why Many See It, Why Some Do Not
Guillermina Lozano1, Carol Prives2, Kanaga Sabapathy3
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
Mutations in the TP53 tumor-suppressor gene in human cancer are unique in that 60% to 70% are of the missense variety, resulting in a full-length protein that is often highly expressed in patients' tumors. These missense mutant proteins often exhibit pro-oncogenic activities (referred to as gain of function) in mouse models and human cell lines and correlate with poor cancer prognosis in some cases.
Insights
Most TP53 gene mutations in cancer are missense, creating full-length proteins with enhanced function. These mutant proteins are linked to tumor growth and worse patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The TP53 tumor-suppressor gene is frequently altered in human cancers.
- A high proportion of TP53 alterations are missense mutations, leading to stable, full-length mutant proteins.
- These mutant TP53 proteins are often overexpressed in tumors.
Purpose of the Study:
- To investigate the functional consequences of TP53 missense mutations in cancer.
- To explore the oncogenic potential and prognostic implications of these mutations.
Main Methods:
- Analysis of TP53 mutation types in human cancer datasets.
- Assessment of TP53 mutant protein expression levels in patient tumors.
- Evaluation of gain-of-function activities in experimental models (mouse models, human cell lines).
Main Results:
- 60-70% of TP53 mutations are missense, producing full-length proteins.
- These missense mutant TP53 proteins frequently display gain-of-function activities.
- Overexpression of mutant TP53 correlates with poor cancer prognosis in certain cancer types.
Conclusions:
- TP53 missense mutations represent a distinct class of genetic alterations in cancer.
- Gain-of-function activities of mutant TP53 proteins contribute to tumorigenesis.
- Mutant TP53 status may serve as a prognostic biomarker in cancer management.
Related Concept Videos
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
02:23Abnormal Proliferation
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...